A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects.

MLA

Sadaf, Alina, et al. “A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects.” Clinical Pharmacokinetics, vol. 63, no. 3, Mar. 2024, pp. 357–65. EBSCOhost, https://doi.org/10.1007/s40262-024-01349-4.

APA

Sadaf, A., Dong, M., Pfeiffer, A., Latham, T., Kalfa, T., Vinks, A. A., Ware, R. E., & Quinn, C. T. (2024). A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects. Clinical Pharmacokinetics, 63(3), 357–365. https://doi.org/10.1007/s40262-024-01349-4

Chicago

Sadaf, Alina, Min Dong, Amanda Pfeiffer, Teresa Latham, Theodosia Kalfa, Alexander A Vinks, Russell E Ware, and Charles T Quinn. 2024. “A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects.” Clinical Pharmacokinetics 63 (3): 357–65. doi:10.1007/s40262-024-01349-4.